Approval · Notice of Compliance 582 · 2002
RATIO-HALOPERIDOL: Notice of Compliance 582
Issued May 14, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 582
- Date
- May 14, 2002
- Company
- Ratiopharm Inc.Ulm, Germany
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer and product name change
- Therapeutic class
- Antipsychotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RATIO-HALOPERIDOL | 00552135 | Cancelled Post Market |
| RATIO-HALOPERIDOL | 00552143 | Cancelled Post Market |
| RATIO-HALOPERIDOL | 00728292 | Cancelled Post Market |
| RATIO-HALOPERIDOL | 00647969 | Cancelled Post Market |
| RATIO-HALOPERIDOL | 00728306 | Cancelled Post Market |
| RATIO-HALOPERIDOL | 00552429 | Cancelled Post Market |
Medicinal ingredients
- HALOPERIDOL 0.5 MG per TAB
- HALOPERIDOL 1 MG per TAB
- HALOPERIDOL 2 MG per TAB
- HALOPERIDOL 5 MG per TAB
- HALOPERIDOL 10 MG per TAB
- HALOPERIDOL 2 MG per ML